You have 9 free searches left this month | for more free features.

Neutralizing Monoclonal Antibodies

Showing 1 - 25 of 9,507

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Coronavirus Infections Trial in Moscow (tixagevimab/cilgavimab 150+150 mg, tixagevimab/cilgavimab 300+300 mg, regdanvimab)

Active, not recruiting
  • Coronavirus Infections
  • tixagevimab/cilgavimab 150+150 mg
  • +2 more
  • Moscow, Russian Federation
    Moscow City Clinical Hospital 52
Aug 7, 2023

TURN-COVID Biobank: The Dutch Cohort Study for Evaluation of Use

Recruiting
  • COVID-19
  • casirivimab with imdevimab
  • +2 more
  • Amsterdam, Noord Holland, Netherlands
  • +3 more
Jan 13, 2022

COVID-19; Isolation of Neutralizing Antibodies for Therapeutics

Active, not recruiting
  • SARS-CoV 2
  • Blood sampling
  • Grenoble, France
    UniversityGrenobleHospital
Mar 24, 2022

HIV Trial in Worldwide (VRC01, VRC01LS, VRC07-523LS)

Completed
  • HIV Infections
  • VRC01
  • +2 more
  • Los Angeles, California
  • +13 more
Dec 19, 2022

Human Immunodeficiency Virus Trial in New York, Philadelphia (3BNC117-LS, 10-1074-LS, N803)

Not yet recruiting
  • Human Immunodeficiency Virus
  • New York, New York
  • +2 more
Jul 12, 2022

COVID-19 : Neutralizing Human Monoclonal Antibodies Against

Completed
  • COVID
  • Blood sample
  • Lyon, France
    Hôpital de la Croix-Rousse
Jun 17, 2021

Acute HIV Infection Trial in Brazil, Peru, United States (biological, other, drug)

Not yet recruiting
  • Acute HIV Infection
  • VRC07-523LS
  • +3 more
  • Birmingham, Alabama
  • +35 more
Jan 30, 2023

Use of nMoABs for the Treatment of COVID-19 in Patients With HM.

Completed
  • Covid19
  • Hematological Malignancy
    • Bari, Italy
    • +13 more
    Jun 21, 2022

    COVID-19, SARS CoV 2 Infection Trial in Orléans (Collection of biological samples)

    Not yet recruiting
    • COVID-19
    • SARS CoV 2 Infection
    • Collection of biological samples
    • Orléans, France
      Centre Hospitalier Régional d'Orléans, France
    Jul 21, 2022

    HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

    Not yet recruiting
    • HIV-1-infection
    • VRC07-523LS
    • +7 more
    • Pathum Wan, Bangkok, Thailand
    • +1 more
    Mar 8, 2023

    Clostridium Infection Trial in Paris (Collection of peripheral blood mononuclear cells)

    Completed
    • Clostridium Infection
    • Collection of peripheral blood mononuclear cells
    • Paris, France
      Maladies infectieuses et tropicales, Hôpital Pitié-Salpêtrière
    Oct 3, 2022

    Hemophilia B Trial (CSL222 (AAV5-hFIXco-Padua))

    Not yet recruiting
    • Hemophilia B
    • CSL222 (AAV5-hFIXco-Padua)
    • (no location specified)
    Aug 14, 2023

    Broadly HIV-1 Neutralizing Antibodies in HIV-infected Mbeya,

    Active, not recruiting
    • HIV/AIDS
      • Mbeya, Tanzania
        NIMR-Mbeya Medical Research Center (MMRC)
      Aug 5, 2022

      HIV Trial in South Africa (VRC01.23LS, PGT121.414.LS, PGDM1400LS)

      Not yet recruiting
      • HIV Infections
      • VRC01.23LS
      • +2 more
      • Cape Town, Western Cape, South Africa
      • +7 more
      Jul 24, 2023

      Hepatitis b Virus Trial in New York (HepB mAb19, Sterile Saline)

      Not yet recruiting
      • Hepatitis b Virus
      • HepB mAb19
      • Sterile Saline
      • New York, New York
      • +1 more
      May 12, 2023

      Japanese Encephalitis, Vaccine Preventable Disease, Vaccine Reaction Trial in Lishui, Quzhou, Wenzhou (Japanese Encephalitis

      Active, not recruiting
      • Japanese Encephalitis
      • +2 more
      • Japanese Encephalitis Vaccine (Vero Cell), Inactivated;
      • No prospective interventions
      • Lishui, Zhejiang, China
      • +2 more
      Nov 13, 2022

      Alzheimer Trial (Lecanemab)

      Not yet recruiting
      • Alzheimer Disease
      • (no location specified)
      Jun 22, 2023

      HIV Trial in Philadelphia (3BNC117-LS, 10-1074-LS)

      Suspended
      • HIV Infections
      • Birmingham, Alabama
      • +5 more
      Jan 31, 2023

      Medicare Anti-Aß mAb Coverage With Evidence Development Study

      Recruiting
      • Mild Alzheimer's Disease
      • Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
      • Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
      • Baltimore, Maryland
        Centers for Medicare and Medicaid Services
      Sep 21, 2023

      Treatment of BK Virus Infection in Hematopoietic Stem Cell

      Recruiting
      • BK Virus Infection
        • Strasbourg, France
          Service Laboratoire de Virologie - PTM - CHU de Strasbourg - Fra
        Nov 8, 2022

        Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment

        Recruiting
        • COVID-19 Convalescent Plasma Treatment
          • Strasbourg, France
            Service des Maladies Infectieuses et Tropicales - CHU de Strasbo
          Jun 15, 2023

          SARS-COV-2/COVID-19 Neutralizing Antibodies in Blood

          Completed
          • SARS-CoV2 Infection
            • Starkville, Mississippi
            • +4 more
            Aug 8, 2022

            HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)

            Not yet recruiting
            • HIV Infections
            • Teropavimab
            • +4 more
            • (no location specified)
            Feb 6, 2023

            Solid Tumor, Adult Trial in Minneapolis, Hackensack, Houston (FT516, Avelumab, Cyclophosphamide)

            Completed
            • Solid Tumor, Adult
            • Minneapolis, Minnesota
            • +2 more
            Jan 27, 2023

            Acquiring Convalescent Specimens for COVID-19 Antibodies

            Completed
            • COVID-19
            • +2 more
            • Blood draw
            • New York, New York
              Columbia University Irving Medical Center/NYP
            Jul 18, 2022